{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:02Z","timestamp":1786119542399,"version":"build-2736575974"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/med.0b013e3283390f8d","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T01:44:43Z","timestamp":1294969483000},"page":"188-193","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of primary aldosteronism"],"prefix":"10.1097","volume":"17","author":[{"given":"Paolo","family":"Mulatero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Monticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bertello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Tizzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Crudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20211004","first-page":"6","article-title":"Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"R2-3-20211004","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","article-title":"Primary aldosteronism","volume":"339","author":"Ganguly","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-3-20211004","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guidelines","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/157340205774574595","article-title":"Diagnosis of surgically treatable forms of primary aldosteronism","volume":"1","author":"Mulatero","year":"2005","journal-title":"Curr Hypert Rev"},{"key":"R8-3-20211004","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jcem-41-5-809","article-title":"Primary aldosteronism due to a malignant ovrian tumor","volume":"41","author":"Todesco","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1056\/NEJM200105173442017","article-title":"Paraneoplastic hyperaldosteronism associated with non-Hodgkin's lymphoma","volume":"344","author":"Mulatero","year":"2001","journal-title":"N Engl J Med"},{"key":"R10-3-20211004","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152506775268776","article-title":"Mineralocorticoid receptor blockade in the protection of target organ damage","volume":"4","author":"Mulatero","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.109.139832","article-title":"Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism","volume":"55","author":"Rossi","year":"2010","journal-title":"Hypertension"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-032179","article-title":"Aldosterone to renin ratio in a primary care setting: the Bussolengo Study","volume":"89","author":"Olivieri","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1373\/clinchem.2004.033654","article-title":"Direct renin assay and plasma rennin activity assay compared","volume":"50","author":"Hartman","year":"2004","journal-title":"Clin Chem"},{"key":"R16-3-20211004","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1521-690X(03)00050-2","article-title":"Primary aldosteronism","volume":"17","author":"Stowasser","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R19-3-20211004","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism-changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"R22-3-20211004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/eje.0.1500329","article-title":"Diagnosis of primary aldosteronism: value of different screening parameters and in\ufb02uence of antihypertensive medication","volume":"150","author":"Seiler","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R23-3-20211004","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1440-1681.1987.tb00967.x","article-title":"Acute haemodynamic and hormonal effects of oral doxazosin in normal subjects","volume":"14","author":"Whitworth","year":"1987","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R24-3-20211004","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/jc.2007-2055","article-title":"Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes","volume":"93","author":"Mulatero","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors influencing out-come of surgery for primary aldosteronism","volume":"131","author":"Celen","year":"1996","journal-title":"Arch Surg"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ajh\/3.5.360","article-title":"Effect of age on response of secondary hypertension to specific treatment","volume":"3","author":"Streeten","year":"1990","journal-title":"Am J Hypertens"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tem.2005.02.006","article-title":"Plasma renin and aldosterone measurements in low renin hypertensive states","volume":"16","author":"Sealey","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R29-3-20211004","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and treatment of low-renin hypertension","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-57-5-892","article-title":"Single dose captopril as a diagnostic test for primary aldosteronism","volume":"57","author":"Lyons","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-3-20211004","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","article-title":"Captopril suppression versus salt loading in confirming primary aldosteronism","volume":"37","author":"Agharazii","year":"2001","journal-title":"Hypertension"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.HYP.0000014324.68506.CA","article-title":"Diagnostic value of the postcaptopril test in primary aldosteronism","volume":"39","author":"Castro","year":"2002","journal-title":"Hypertension"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"R36-3-20211004","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.hjh.0000217857.20241.0f","article-title":"Analysis of screening and con\ufb01rmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol","volume":"24","author":"Giacchetti","year":"2006","journal-title":"J Hypertens"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/ajh.2009.89","article-title":"Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests","volume":"22","author":"Wu","year":"2009","journal-title":"Am J Hypertens"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","author":"Stowasser","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2006-0078","article-title":"Comparison of confirmatory tests for the diagnosis of primary aldosteronism: diagnosis of PA","volume":"91","author":"Mulatero","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"key":"R41-3-20211004","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","article-title":"Captopril test can give misleading results in patients with suspect primary aldosteronism","volume":"50","author":"Mulatero","year":"2007","journal-title":"Hypertension"},{"key":"R42-3-20211004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11906-009-0038-1","article-title":"Differential diagnosis of primary aldosteronism subtypes","volume":"11","author":"Mulatero","year":"2009","journal-title":"Curr Hypertens Rep"},{"key":"R43-3-20211004","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"R44-3-20211004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","article-title":"Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome","volume":"141","author":"Nwariaku","year":"2006","journal-title":"Arch Surg"},{"key":"R45-3-20211004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11154-007-9055-z","article-title":"Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism","volume":"8","author":"Young","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"R46-3-20211004","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0895-7061(01)02312-3","article-title":"Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning","volume":"15","author":"Mansoor","year":"2002","journal-title":"Am J Hypertens"},{"issue":"Suppl. 1","key":"R47-3-20211004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000173946","article-title":"Primary aldosteronism: diagnosis and noninvasive lateralization procedures","volume":"72","author":"Vetter","year":"1985","journal-title":"Cardiology"},{"key":"R48-3-20211004","first-page":"43","article-title":"Limited signi\ufb01cance of asymmetric adrenal visualisation on dexamethasone suppression scintigraphy","volume":"26","author":"Gross","year":"1985","journal-title":"J Nucl Med"},{"key":"R49-3-20211004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2265.2008.03450.x","article-title":"What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?","volume":"70","author":"Young","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R50-3-20211004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiology.198.2.8596821","article-title":"Hyperaldosteronism: sampling the adrenal veins","volume":"198","author":"Doppman","year":"1996","journal-title":"Radiology"},{"key":"R51-3-20211004","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.109.134759","article-title":"Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism","volume":"54","author":"Miotto","year":"2009","journal-title":"Hypertension"},{"key":"R52-3-20211004","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","article-title":"Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases","volume":"86","author":"Rossi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-3-20211004","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u201cnonselective\u201d screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"R54-3-20211004","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(18)30425-0","article-title":"Primary aldosteronism. Diagnostic evaluation","volume":"17","author":"Young","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R55-3-20211004","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1373\/clinchem.2007.092080","article-title":"Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism","volume":"53","author":"Mengozzi","year":"2007","journal-title":"Clin Chem"},{"key":"R56-3-20211004","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/HYPERTENSIONAHA.109.146613","article-title":"Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism","volume":"55","author":"Mulatero","year":"2010","journal-title":"Hypertension"},{"key":"R57-3-20211004","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","article-title":"Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols","volume":"53","author":"Seccia","year":"2009","journal-title":"Hypertension"},{"key":"R58-3-20211004","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"R59-3-20211004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004872-200404000-00001","article-title":"Genetics of primary aldosteronism","volume":"22","author":"Mulatero","year":"2004","journal-title":"J Hypertens"},{"key":"R60-3-20211004","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","article-title":"Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families","volume":"26","author":"Sukor","year":"2008","journal-title":"J Hypertens"},{"key":"R61-3-20211004","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)","volume":"37","author":"Lafferty","year":"2000","journal-title":"J Med Genet"},{"key":"R62-3-20211004","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"R63-3-20211004","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of humanMendelian hypertension featuring nonglucocorticoid remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-3-20211004","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1210\/jc.2008-1241","article-title":"A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III","volume":"93","author":"Mulatero","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R65-3-20211004","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary aldosteronism: factors associated with normalization of blood pressure after surgery","volume":"135","author":"Sawka","year":"2001","journal-title":"Ann Intern Med"},{"key":"R66-3-20211004","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-3-20211004","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R68-3-20211004","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","article-title":"Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism","volume":"9","author":"Karagiannis","year":"2008","journal-title":"Expert Opin Pharmacother"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-201006000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:47:49Z","timestamp":1786042069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-201006000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e3283390f8d","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}